SCHEMBL4940575

SCHEMBL4940575

O=C(O)c1ccc2c(S(=O)(=O)O)c(O)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.48
CYP2D6 P10635 1/20 0.48
KDM4E B2RXH2 3/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
PTGS2 P35354 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PTPN1 P18031 1/20 0.46
RARB P10826 2/20 0.42
RARG P13631 2/20 0.42
LCK P06239 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1791108 0.84 PTPN1 (0.54) ERN1CYP2D6KDM4EPOLBL3MBTL1
SCHEMBL7583560 0.83 CDC25B (0.50) ERN1CYP2D6KDM4ECA12CA1
SCHEMBL9845612 0.83 PTPN1 (0.53) ERN1CYP2D6KDM4EPOLBL3MBTL1
SCHEMBL3888687 0.83 PTPN1 (0.53) ERN1CYP2D6KDM4EPOLBL3MBTL1
SCHEMBL30046904 0.83 PTPN1 (0.53) ERN1CYP2D6KDM4ECA12CA1
SCHEMBL9011319 0.80 MPL (0.51) ERN1CYP2D6CA2L3MBTL1HPGD
SCHEMBL29653686 0.80 MPL (0.51) ERN1CYP2D6CA2L3MBTL1HPGD
SCHEMBL10508205 0.78 NT5E (0.54) CYP2D6KDM4EGAAMAPTPRMT1
SCHEMBL3391145 0.78 LCK (0.65) ERN1KDM4ECA12CA1CA2
SCHEMBL9618790 0.78 KDM4E (0.55) ERN1CYP2D6KDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1549598-A4 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) CORTICAL PTY LTD (AU) 2008-01-23 EP claimed
US-20060106102-A1 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) Morand, Eric 2006-05-18 US claimed
CN-1675154-A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) CORTICAL PTY LTD (AU) 2005-09-28 CN claimed
EP-1549598-A1 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) Cortical Pty Ltd (AU) 2005-07-06 EP claimed
WO-2003104178-A1 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) CORTICAL PTY LTD (AU) 2003-12-18 WO claimed
EP-0502893-A1 AZO COMPOUNDS AND THEIR USE AS DYES, 1-SULPHO-6-CARBOXYL-AMINO NAPHTHALINE, ITS USE AS A DIAZO COMPONENT AND PROCESS FOR THE PRODUCTION OF THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-16 EP claimed
WO-1991008265-A1 AZO COMPOUNDS AND THEIR USE AS DYES, 1-SULPHO-6-CARBOXYL-AMINO NAPHTHALINE, ITS USE AS A DIAZO COMPONENT AND PROCESS FOR THE PRODUCTION OF THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-13 WO claimed
EP-1549598-A4 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) CORTICAL PTY LTD (AU) 2008-01-23 EP disclosed
US-20060106102-A1 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) Morand, Eric 2006-05-18 US disclosed
CN-1675154-A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF) CORTICAL PTY LTD (AU) 2005-09-28 CN disclosed
EP-1549598-A1 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) Cortical Pty Ltd (AU) 2005-07-06 EP disclosed
WO-2003104178-A1 NAPTHTHALENE DERIVATIVES WHICH INHIBIT THE CYTOKINE OR BIOLOGICAL ACTIVITY OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) CORTICAL PTY LTD (AU) 2003-12-18 WO disclosed
EP-0507801-B1 AZO COMPOUNDS, PROCESS FOR PRODUCING THEM AND THEIR USE AS COLORANTS HOECHST AG (DE) 1994-08-10 EP disclosed
US-5268458-A Azo compounds, having a 1-sulfo-6-carboxy-2-naphthyl group as the diazo component and a halogen-substituted heterocyclic fiber-reactive group HOECHST AKTIENGESELLSCHAFT (DE) 1993-12-07 US disclosed
EP-0507801-A1 AZO COMPOUNDS, PROCESS FOR PRODUCING THEM AND THEIR USE AS COLORANTS. HOECHST AG (DE) 1992-10-14 EP disclosed
EP-0507822-A1 AZO COMPOUNDS, PROCESS FOR PRODUCING THEM AND THEIR USE AS DYES. HOECHST AG (DE) 1992-10-14 EP disclosed
EP-0502893-A1 AZO COMPOUNDS AND THEIR USE AS DYES, 1-SULPHO-6-CARBOXYL-AMINO NAPHTHALINE, ITS USE AS A DIAZO COMPONENT AND PROCESS FOR THE PRODUCTION OF THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1992-09-16 EP disclosed
WO-1991009913-A1 AZO COMPOUNDS, PROCESS FOR PRODUCING THEM AND THEIR USE AS DYES HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-11 WO disclosed
WO-1991009914-A1 AZO COMPOUNDS, PROCESS FOR PRODUCING THEM AND THEIR USE AS COLORANTS HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-11 WO disclosed
WO-1991008265-A1 AZO COMPOUNDS AND THEIR USE AS DYES, 1-SULPHO-6-CARBOXYL-AMINO NAPHTHALINE, ITS USE AS A DIAZO COMPONENT AND PROCESS FOR THE PRODUCTION OF THESE COMPOUNDS HOECHST AKTIENGESELLSCHAFT (DE) 1991-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106102-A1 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif) MIF, ARG1, MSR1 ERN1 3312/4885CYP2D6 1338/4885KDM4E 3166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.